Scott Evans

13.1k citations

194 papers · 6.5k indexed · 4 hit papers · h-index 40

Impact in

Virology top 0.2%
- HIV Research and Treatment
Applied Microbiology and Biotechnology top 0.2%
- Antibiotic Use and Resistance

Papers in ⓘ

Applied Microbiology and Biotechnology 28
- Antibiotic Use and Resistance 28
Statistics and Probability 55
- Statistical Methods in Clinical Trials 50

Co-authors: David B. Clifford (20 shared papers)Ronald J. Ellis (12 shared papers)Vance G. Fowler (43 shared papers)Justin C. McArthur (7 shared papers)Kunling Wu (6 shared papers)Ronald J. Bosch (5 shared papers)Robert A. Bonomo (26 shared papers)Ann C. Collier (4 shared papers)
Journals: Clinical Infectious Diseases (35 papers)Open Forum Infectious Diseases (14 papers)Statistics in Biopharmaceutical Research (12 papers)AIDS (8 papers)HIV Clinical Trials (8 papers)
Partner nations: United States Japan Sweden

In The Last Decade

Scott Evans

180 papers receiving 6.3k citations

Hit Papers

align trajectories log scale

Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children 2022 · 80 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 JAMA Pediatrics
2020 New England Journal of Medicine
2017 Clinical Infectious Diseases
2007 AIDS

Peers

Countries citing papers authored by Scott Evans

Since Specialization

Citations

This map shows the geographic impact of Scott Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott Evans more than expected).

Fields of papers citing papers by Scott Evans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott Evans. The network helps show where Scott Evans may publish in the future.

Co-authors

The 25 scholars most cited alongside Scott Evans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Scott Evans Line = papers co-authored together Scott Evans links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 194 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	The prevalence and incidence of neurocognitive impairment in the HAART era AIDS ·Kevin R. Robertson, Marlene Smurzynski, Thomas D. Parsons, Kunling Wu, Ronald J. Bosch, Julia Wu, Justin C. McArthur, Ann C. Collier, Scott Evans, Ronald J. Ellis Hit paper breakdown →	2007	504
2	Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae Clinical Infectious Diseases ·David van Duin, Judith J. Lok, Michelle Earley, Eric Cober, Sandra S. Richter, Federico Pérez, Robert A. Salata, Robert C. Kalayjian, Richard Watkins, Yohei Doi, Keith S. Kaye, Vance G. Fowler, David L. Paterson, Robert A. Bonomo, Scott Evans, (unknown) Hit paper breakdown →	2017	479
3	Ticagrelor and Aspirin or Aspirin Alone in Acute Ischemic Stroke or TIA New England Journal of Medicine ·S. Claiborne Johnston, Pierre Amarenco, Hans Denison, Scott Evans, Anders Himmelmänn, Stefan James, Mikael Knutsson, Per Ladenvall, Carlos A. Molina, Yongjun Wang Hit paper breakdown →	2020	304
4	Impact of combination antiretroviral therapy on cerebrospinal fluid HIV RNA and neurocognitive performance AIDS ·Christina M. Marra, Yu Zhao, David B. Clifford, Scott Letendre, Scott Evans, Katherine Henry, Ronald J. Ellis, Benigno Rodríguez, Robert W. Coombs, Giovanni Schifitto, Justin C. McArthur, Kevin Robertson	2009	259
5	Impact of Efavirenz on Neuropsychological Performance and Symptoms in HIV-Infected Individuals Annals of Internal Medicine ·David B. Clifford, Scott Evans, Yijun Yang, Edward P. Acosta, Karl Goodkin, Karen T. Tashima, David M. Simpson, David Dorfman, Heather J. Ribaudo, Roy M. Gulick, (unknown)	2005	216
6	Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR) Clinical Infectious Diseases ·Scott Evans, Daniel B. Rubin, Dean Follmann, Gene Pennello, W. Charles Huskins, John H. Powers, David Schoenfeld, Christy Chuang‐Stein, Sara E. Cosgrove, Vance G. Fowler, Ebbing Lautenbach, Henry F. Chambers	2015	200
7	Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort Neurology ·K. R. Robertson, Zhaohui Su, David M. Margolis, Amy Krambrink, Diane V. Havlir, Scott Evans, Daniel J. Skiest	2010	167
8	Effects of central nervous system antiretroviral penetration on cognitive functioning in the ALLRT cohort AIDS ·Marlene Smurzynski, Kunling Wu, Scott Letendre, Kevin Robertson, Ronald J. Bosch, David B. Clifford, Scott Evans, Ann C. Collier, Michael Taylor, Ronald J. Ellis	2010	165
9	MEASURING AND TESTING FOR SPATIAL SYNCHRONY Ecology ·John P. Buonaccorsi, Joseph S. Elkinton, Scott Evans, Andrew M. Liebhold	2001	151
10	Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality Clinical Infectious Diseases ·Laura J. Rojas, Madiha Salim, Eric Cober, Sandra S. Richter, Federico Pérez, Robert A. Salata, Robert C. Kalayjian, Richard Watkins, Steve H. Marshall, Susan D. Rudin, Tatiana Domitrovic, Andrea M. Hujer, Kristine M. Hujer, Yohei Doi, Keith S. Kaye, Scott Evans, Vance G. Fowler, Robert A. Bonomo, David van Duin, (unknown)	2016	150
11	Clinical trial structures PubMed ·Scott Evans	2010	148
12	Peripheral neuropathy in HIV: prevalence and risk factors AIDS ·Scott Evans, Ronald J. Ellis, Huichao Chen, Tzu-min Yeh, Anthony Lee, Giovanni Schifitto, Kunling Wu, Ronald J. Bosch, Justin C. McArthur, David M. Simpson, David B. Clifford	2011	140
13	Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects AIDS ·Raymond T. Chung, Scott Evans, Yijun Yang, Dickens Theodore, Hernan Valdez, Rebecca A. Clark, Cecilia M. Shikuma, Thomas Nevin, Kenneth E. Sherman	2002	131
14	Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies Annals of Internal Medicine ·Hajime Uno, Janet Wittes, Haoda Fu, Scott D. Solomon, Brian Claggett, Lü Tian, Tianxi Cai, Marc A. Pfeffer, Scott Evans, Lee‐Jen Wei	2015	128
15	HIV neuropathy natural history cohort study Neurology ·David M. Simpson, Douglas Kitch, Scott Evans, Justin C. McArthur, David M. Asmuth, Bruce A. Cohen, Karl Goodkin, Mariana Gerschenson, Y. So, Christina M. Marra, Ramon Diaz‐Arrastia, S. Shriver, Linda Millar, David B. Clifford, (unknown)	2006	126
16	Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trial The Lancet Neurology ·Pierre Amarenco, Gregory W. Albers, Hans Denison, J. Donald Easton, Scott Evans, Peter Held, Michael D. Hill, Jenny Jonasson, Scott E. Kasner, Per Ladenvall, Kazuo Minematsu, Carlos A. Molina, Yongjun Wang, Ka Sing Wong, S. Claiborne Johnston	2017	119
17	A Randomized Trial of the Efficacy and Safety of Fenofibrate versus Pravastatin in HIV-Infected Subjects with Lipid Abnormalities: AIDS Clinical Trials Group Study 5087 AIDS Research and Human Retroviruses ·Judith A. Aberg, Robert Zackin, Susan W. Brobst, Scott Evans, Beverly Alston, W. Keith Henry, Marshall J. Glesby, Francesca J. Torriani, Yijun Yang, Susan Owens, Carl J. Fichtenbaum	2005	97
18	Using Outcomes to Analyze Patients Rather than Patients to Analyze Outcomes: A Step Toward Pragmatism in Benefit:Risk Evaluation Statistics in Biopharmaceutical Research ·Scott Evans, Dean Follmann	2016	85
19	Long-Term Impact of Efavirenz on Neuropsychological Performance and Symptoms in HIV-Infected Individuals (ACTG 5097s) HIV Clinical Trials ·David B. Clifford, Scott Evans, Yijun Yang, Edward P. Acosta, Heather J. Ribaudo, Roy M. Gulick, (unknown)	2009	83
20	Spectrum of excess mortality due to carbapenem-resistant Klebsiella pneumoniae infections Clinical Microbiology and Infection ·Christopher G. Hauck, Eric Cober, Sandra S. Richter, Federico Pérez, Robert A. Salata, Robert C. Kalayjian, Richard Watkins, Nikole M. Scalera, Yohei Doi, Keith S. Kaye, Scott Evans, Vance G. Fowler, Robert A. Bonomo, David van Duin	2016	80

About Scott Evans

Scott Evans is a scholar working on Applied Microbiology and Biotechnology, Statistics and Probability, Virology, Molecular Medicine and Statistics, Probability and Uncertainty, having authored 194 papers that have together received 6.5k indexed citations. Recurring topics across this work include Statistical Methods in Clinical Trials (50 papers), Health Systems, Economic Evaluations, Quality of Life (40 papers), Antibiotic Use and Resistance (28 papers), Antibiotic Resistance in Bacteria (28 papers), Meta-analysis and systematic reviews (27 papers), HIV Research and Treatment (27 papers), Bacterial Identification and Susceptibility Testing (23 papers) and HIV-related health complications and treatments (19 papers). The work is most often cited by research in Virology (1.9k citations), Applied Microbiology and Biotechnology (639 citations), Molecular Medicine (1.1k citations), Emergency Medicine (1.3k citations) and Infectious Diseases (1.9k citations). Scott Evans has collaborated with scholars based in United States, Japan and Sweden. Frequent co-authors include David B. Clifford, Ronald J. Ellis, Vance G. Fowler, Justin C. McArthur, Kunling Wu, Ronald J. Bosch, Robert A. Bonomo, Ann C. Collier, Yijun Yang and Dean Follmann. Their work appears in journals such as Clinical Infectious Diseases, Open Forum Infectious Diseases, Statistics in Biopharmaceutical Research, AIDS and HIV Clinical Trials.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact